ADAG
Adagene Inc. American Depositary Shares
$1.950+-0.000 (-0.000%)
Precio en Tiempo Real
Gráfico de Precios
Loading Chart...
Métricas Clave
Métricas de Mercado
Apertura
$1.950
Máximo
$1.950
Mínimo
$1.950
Volumen
0.00M
Fundamentos de la Empresa
Estadísticas de Negociación
Noticias Relacionadas
GlobeNewswire
Adagene to Present at Jefferies Global Healthcare Conference 2025
SAN DIEGO and SUZHOU, China, May 27, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. ("Adagene") (NASDAQ:ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that
Ver más
GlobeNewswire
Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting
CTLA-4 inhibitor ADG126 can be dosed at 20 mg/kg Q6W in combination with pembrolizumab with <20% Grade 3 adverse events In combination with pembrolizumab, ADG126 showed a 29% confirmed overall response rate (ORR)
Ver más
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.